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Abstract 
Corneal decellularization has become an increasingly popular technique for generating 
scaffolds for corneal regeneration. Most decellularization procedures result in tissue swelling, 
thus limiting their application. Here the use of a polysaccharide, dextran, to reduce swelling 
and conserve the native corneal structure during decellularization was investigated. Corneas 
were treated with 1% Triton X-100, 0.5% SDS and nucleases under constant rotation 
followed by extensive washing. To reduce swelling, decellularization solutions were 
supplemented with 5% dextran either throughout the whole decellularization process or 
during the washing cycles only. Quantitative analysis of DNA content showed a 96% 
reduction after decellularization regardless of the addition of dextran. Dextran resulted in a 
significant reduction in swelling from 3.85 ± 0.43 nm without to 1.94 ± 0.29 - 2.01 ± 0.37 nm 
(p < 0.05) remaining at similar dimensions to the native tissue (1.73 ± 0.23 nm). Tissue 
transparency was restored to all decellularized corneas following submersion in glycerol. 
TEM analysis found that dextran must be present throughout the decellularization protocol to 
preserve the native corneal architecture, anisotropy analysis demonstrated comparable results 
(0.22 ± 0.03) to the native cornea (0.24 ± 0.02), p > 0.05. Dextran can counteract the 
detrimental effects of decellularizing agents on the biomechanical properties of the tissue 
resulting in similar compressive moduli (mean before decellularization: 5.40 ± 1.18 kPa; 
mean after decellularization with dextran: 5.64 ± 1.34 kPa, p > 0.05). Cells remained viable 
in the presence of decellularized scaffolds. The findings of this study indicate that dextran not 
only prevents significant corneal swelling during decellularization but also enhances the 
maintenance of the native corneal ultrastructure. 
Keywords: Cornea, decellularization, swelling, extracellular matrix, ultrastructure, 
transparency, residual DNA, collagen, glycosaminoglycans  
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Introduction 
Corneal blindness affects millions worldwide and represents a significant global health 
challenge (1, 2). In many cases, the only therapeutic option is keratoplasty (3). This approach, 
suffers a number of limitations including a shortage of suitable donor tissue in many 
countries. In recent years, corneal tissue engineering has emerged as a promising alternative 
to transplantation and significant progress has been made in this area with keratoprostheses 
(4, 5), xenografts (6-8) and tissue-engineered corneas (9) entering clinical or pre-clinical 
development.   
Tissue-engineering approaches rely on the fabrication of biomimetic corneal scaffolds using 
synthetic and naturally-derived polymeric biomaterials (10-17). These scaffolds often fail to 
replicate the complex native structural and biochemical architecture of cornea (18). 
Decellularized corneas overcome many of the limitations of other tissue-engineered methods 
since the inherent structural features are already present in the scaffold, they possess the 
required nanoscale topography and intrinsic biological cues reside within the matrix that 
support healthy cell phenotypes (19). Decellularization involves removing nuclear and 
cellular material whilst preserving the structural components of the extracellular matrix 
(ECM) (20). Scaffolds derived by this method from a variety of tissues and organs have had 
clinical success (21, 22), however, worldwide shortage of viable cadaveric corneal tissue has 
led to the exploration of alternative tissue sources. 
Xenogenic porcine corneal scaffolds have attracted considerable interest in recent years (23-
25), since they are inexpensive, readily available, and possess similar dimensional and 
refractive properties compared to human corneas (8). Decellularization of porcine tissue has 
been achieved through multiple methods; however, as yet, a universal set of standardized 
protocols has not been outlined. A significant problem arising from decellularization 
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processes is corneal swelling, limiting its potential use as a scaffold. Tissue swelling results 
in a scaffold with dimensions incompatible with the human eye and thus is unsuitable for 
transplantation. In addition, the highly organized ECM architecture that is essential to corneal 
transparency (26, 27) becomes disrupted after swelling and decellularization treatments 
leading to a reduction in the optical clarity of the cornea. Furthermore, ECM damage can 
alter the mechanical properties of the cornea (28). The mechanical properties of the native 
corneas must be approximated in any successful corneal replacement, and is required to 
withstand internal and external forces that are applied to the eye, e.g. intraocular and eyelid 
pressure and eye rubbing (29-31). Dextran is a complex polysaccharide routinely used at a 
concentration of 5% to act as a deswelling agent during organ culture to preserve human 
corneas (32-35) although to date its use in controlling swelling during decellularization has 
not been investigated. Dextran increases colloidal osmotic pressure in cornea storage 
medium, limiting movement of water into the stroma by maintaining a high osmotic pressure 
(34).  In this study, we systematically evaluated the effect of dextran on swelling and 
ultrastructural maintenance of the cornea during decellularization. 
 
Methods 
All chemicals and reagents were purchased from Sigma-Aldrich, unless otherwise stated. 
 
Dissection of porcine corneas 
Adult porcine eyes were obtained from a local abattoir within 2 h post mortem. 8 mm corneal 
buttons were dissected and washed for 18 h in phosphate buffered saline (PBS) containing 
2% (v/v) antibiotic/antimycotic (0.02 μg/mL gentamycin, 0.5 ng/mL amphotericin B 
combination, Gibco; hereafter referred to as antibiotic/antimycotic wash solution). 
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Generation of an acellular porcine scaffold 
Four corneal groups were tested: (i) agitated control, 2% antibiotic/antimycotic wash 
solution; (ii) detergent treatment, 0.5% (w/v) sodium dodecyl sulphate (SDS) and 1% (v/v) 
Triton X-100 in diH2O; (iii) detergent/dextran treatment, as detergent treatment with the 
addition of 5% (w/v) dextran throughout the procedure; (iv) detergent/dextran wash 
treatment, as detergent treatment followed by washing in 5% dextran. An additional control 
group, native cornea, represented freshly dissected corneas that did not undergo processing, 
except for brief washing in 2% antibiotic/antimycotic wash solution before analysis. All 
conditions were mechanically agitated on a gyratory rocker at 70 rpm for 72 h at room 
temperature (RT).  Corneas, except agitated control, were then treated with nucleases as 
previously described (12) . All corneas were then washed for 48 h with PBS containing 1% 
antibiotic/antimycotic. This was supplemented with 5% dextran for the detergent/dextran and 
detergent/dextran wash groups.  
 
Scaffold swelling 
Following decellularization, corneal swelling was analysed. Images were recorded using a 
stereo microscope (Leica S6 D, Leica Microsystems) coupled to a digital camera (Canon 
PowerShot S50 5MP, Canon). Corneal thickness was measured at the centre of the tissue with 
a micrometre calliper (Silverline) using 12 individual samples for each condition. 
 
Corneal transparency and light transmittance 
To evaluate changes in transparency porcine corneas were imaged following 
decellularization. Subsequently the corneas were submerged in 100% glycerol for 18 h to 
examine restoration of corneal clarity. Light transmittance was quantified before and after 
glycerol treatment. The absorbance of light at several different wavelengths ranging from 350 
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- 700 nm was determined with a microplate reader (BioTek™ Synergy HTX), as previously 
described (12). The transmittance of light was calculated by inverting the absorbance reading. 
Ultrapure water was used as a baseline control. Images were also recorded of the letter A 
through the corneas to give a visual representation of the difference in transparency. 
 
Biochemical Analysis 
Corneal buttons were freeze-dried (Christ-Alpha 1-4 LSC Freeze Dryer) and the dry weight 
was recorded. Corneas were digested in a papain solution (125 µg/mL) in 0.2 M sodium 
phosphate buffer, 5 mM disodium ethylenediaminetetraacetic acid, 10 mM cysteine 
hydrochloride, pH 6.4 for 18 h at 65°C, as previously described (36). DNA was extracted and 
purified using a DNeasy Blood and Tissue Kit (Qiagen) and was quantified with a Quant-
iT™ PicoGreen® dsDNA Assay Kit (Molecular Probes) according to the manufacturer’s 
instructions. Fluorescence was measured at an excitation wavelength of 480 nm and an 
emission wavelength of 520 nm (Tecan Infinite® 200 PRO).  
 
Sulphated glycosaminoglycan (sGAG) content was determined using a 1,9 dimethyl 
methylene blue (DMMB) assay (Biocolor) according to the manufacturer’s protocol . DMMB 
dye was added to papain-digested samples and mixed thoroughly. The solution was then 
centrifuged and the supernatant removed. The remaining pellet was resuspended in 
dissociation dye and the sGAG content was measured by reading the absorbance at 656 nm. 
 
Collagen content was determined using a Sircol™ soluble collagen assay (Bicolor) according 
to the manufacturer’s protocol. First, freeze-dried corneas were digested at 4 °C in pepsin 
extraction reagent (0.1 mg/mL in 0.5 M acetic acid) for 18 h. Sircol™ dye reagent was added 
to pepsin-digested samples and mechanically agitated for 30 min before being centrifuged. 
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The pellet was washed in ice-cold acid salt and centrifuged. The pellet was resuspended in 
Alkali reagent and collagen content was measured by reading the absorbance of the solution 
at 555 nm. Values for each assay were calculated by interpolation from a standard curve and 
normalized to dry weight. 
 
Histological staining 
Scaffolds were fixed in 4 % paraformaldehyde for 18 h. Samples were then dehydrated 
through a graded series of alcohol from 70 % to 100 % followed by immersion in xylene. 
Samples were then embedded in paraffin wax and 5 μm sections were cut using a microtome 
(Leica RM2125, Leica Biosystems). Hematoxylin and eosin (H&E) staining was used to 
visualize cell presence, while 1% alcian blue 8GX solution and picrosirius red staining was 
performed to examine sGAG and collagen retention, respectively. All samples were imaged 
using an inverted light microscope coupled to a digital camera (Olympus BX 41, Olympus). 
For nuclear staining, slides were incubated with 4’, 6-diamidino-2-phenylindole (1:500; 
DAPI) and imaged using an inverted epifluorescent microscope (Olympus IX 71, Olympus). 
 
Mechanical testing 
Unconfined compression experiments were performed. Samples were mechanically tested 
between two flat impermeable platens connected to 5N load cell (Zwick Z005, Zwick Roell) 
as previously described (37). Samples were pre-loaded to 10 % strain and allowed to fully 
relax. The samples were then dynamically loaded at frequencies of 0.1 Hz and 1 Hz. The 
compressive modulus was calculated from the first loading cycle while the dynamic modulus 
was calculated from the average stress and strain amplitude values over 5 cycles.   
 
Transmission Electron Microscopy (TEM) 
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Decellularized scaffolds were fixed in 3% glutaraldehyde in sodium cacodylate buffer 
solution (0.2M, pH 7.2) for 18 h at 4˚C. The scaffolds were post-fixed with 1% osmium 
tetroxide in sodium cacodylate buffer solution for 2 h at room temperature, followed by 
washing in sodium cacodylate buffer (0.1M, pH 7.2), serial dehydrations in ethanol and 
washing in propylene oxide (TAAB Laboratories Equipment Ltd.). The scaffolds were 
embedded in araldite resin (TAAB Laboratories Equipment Ltd.) and sectioned (Leica EM 
UC6, Leica Biosystems). Ultrathin sections (90 µm) were contrasted with uranyl acetate and 
lead citrate and observed on a transmission electron microscope (FEI Tecnai Biotwin T12), 
operating at 100 kV. Images were recorded using a SIS Megaview digital camera (Olympus). 
Collagen fibril alignment was quantified using FibrilTool, an Image J (NIH) plug-in, as 
previously described (38). This plug-in applies circular statistics to analyse variance in 
tangent direction establishing whether fibrils are well ordered. A score is applied, 0 for no 
order or isotropic fibrils and 1 for perfectly ordered or anisotropic fibrils. Five distinct 
regions were chosen in 3 or 4 images for each condition and the anisotropy of collagen fibrils 
was measured.  Fibril diameter was determined using the line drawing tool in Image J and 
was measured relative to the length of a 1 μm scale bar. 
 
Evaluation of scaffold biocompatibility 
Human keratocyte-derived fibroblast cells were cultured in the presence of decellularized 
corneas to evaluate biocompatibility. Cells were isolated as previously described (39) in 
accordance with the Declaration of Helsinki and cultured in low glucose Dulbecco’s 
Modified Eagle’s Medium supplemented with 10% (v/v) foetal bovine serum (FBS; 
Hyclone), 100 U/mL penicillin (Gibco); 100 μg/mL streptomycin (Gibco) and 250 ng/mL 
amphotericin-B, hereafter called lgDMEM. 1 x 10
5
 passage 4 cells were seeded into 6-well 
plates (Grenier Bio-One) and allowed to adhere at 37 °C for 18 h.  Corneal buttons were 
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placed in 6-well ThinCert™ culture inserts (Grenier Bio-One) with pore size of 1 μm above 
the cells. All scaffolds were cultured in lgDMEM. Fibroblasts alone formed the control 
group. In addition, cells were cultured in lgDMEM supplemented with 5 % dextran, termed 
cells (DM), to examine its effect on cell viability. Cell viability was assessed at 0, 3, 7 and 14 
days using a PrestoBlue™ assay (Molecular Probes) according to the manufacturer’s 
instructions. Results were calculated relative to viability at day 0.  
 
Statistics 
Statistical analysis was performed using GraphPad Prism software (GraphPad Software Inc., 
CA, USA). All data are represented as mean ± standard deviation. The statistical differences 
were evaluated by either One-Way or Two-Way ANOVA, followed by Bonferroni’s multiple 
comparisons tests. Significance was accepted at a level of p < 0.05. 
 
Results 
Scaffold swelling and hydration 
All scaffolds underwent a degree of swelling compared to freshly dissected native corneas 
(Fig. 1A). The average thickness of native corneas was 1.73 ± 0.23 mm while the thickness 
of agitated control (9.59 ± 1.07 mm) and detergent only corneas (3.85 ± 0.43 mm) were 
significantly greater (Fig. 1B). Scaffolds decellularized using protocols containing dextran 
were more comparable to the native corneas with a mean thickness of 2.01 ± 0.37 mm for 
detergent/dextran and 1.94 ± 0.29 mm for detergent/dextran wash. Dextran treated corneas 
were significantly thinner than scaffolds decellularized using detergent only. Percentage 
swelling was also analysed (Fig. 1C), the mean increase in swelling compared to the native 
cornea (100.00 ± 0.00 %) for each treatment was as follows, 554.80 ± 61.98 % for agitated 
control, 222.80 ± 24.89 % for detergent both significantly greater than the native cornea. 
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While detergent/dextran and detergent/dextran wash had increases of 116.39 ± 21.61 % and 
112.34 ± 16.20 %, respectively, with no significant difference to the native tissue. 
 
Light transmittance and corneal transparency 
There was a significant difference in the transparency and light transmittance of native 
corneas and decellularized corneas immediately after treatment at all the wavelengths 
analysed (Fig. 2A and B). In all cases, the treated corneas transmitted significantly less light 
than the native controls. Images recorded of the corneas demonstrate the difference in 
transparency before and after decellularization treatment. To examine the restoration of 
corneal clarity the scaffolds were soaked in 100 % glycerol and light transmittance was 
examined after 18 h (Fig. 2C). All corneas, except the agitated control, transmitted 
significantly more light than the native cornea after 18 h. Detergent/dextran and 
detergent/dextran wash had similar levels of light transmittance to the native cornea that was 
treated with glycerol (+ Gly), with detergent/dextran showing no significant difference. The 
images show that all decellularized corneas regained a level of transparency (Fig. 2A).  
    
Residual porcine DNA 
H&E and DAPI analysis showed cells and nuclei present throughout the cornea before 
decellularization, while none remained after decellularization treatments (Fig. 3A). Cells 
were still visible in the agitated control group. Quantification of DNA revealed that 
irrespective of the decellularization protocol, there was a significant reduction of DNA 
compared to native corneas (Fig. 3B). The mean DNA content of native and agitated control 
corneas was 3,335.84 ± 343.27 and 1494.78 ± 100.76 ng/mg respectively, while the yield 
from decellularized scaffolds was 120.00 ± 53.28, 124.82 ± 20.40, and 111.61 ± 12.54 ng/mg 
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for detergent, detergent/dextran, and detergent/dextran wash corneas. This technique resulted 
in an average reduction in DNA of 96 %.  
 
sGAG and collagen content following decellularization 
Quantitative results revealed that all decellularization protocols caused a significant reduction 
in sGAG content compared to native corneas (Fig. 4A). Native and agitated controls 
contained 7.98 ± 0.22 and 6.59 ± 0.74 μg/mg sGAG respectively. Detergent alone retained 
2.14 ± 0.15 μg/mg of sGAG while detergent/dextran and detergent/dextran wash had levels of 
3.87 ± 0.45 and 2.92 ± 0.22 μg/mg respectively. Histological staining with alcian blue 
demonstrated that all decellularized corneas displayed significantly weaker staining for 
sGAG (Fig. 4C). The collagen content within the samples was maintained after 
decellularization with no significant difference from the control samples, all contained ~ 0.8 
mg/mg collagen (Fig. 4B). Histological staining with picrosirius red confirmed these findings 
(Fig. 4C). 
 
Mechanical properties of decellularized corneas 
To examine the effect of decellularization on the corneal mechanical properties dynamic and 
compressive loading tests were performed (Fig. 5). The compressive modulus of agitated 
control (2.04 ± 0.94 kPa), detergent (1.86 ± 0.85 kPa) and detergent/dextran wash (3.65 ± 
1.16 kPa) corneas was significantly lower than the native cornea (5.40 ± 1.18 kPa), while 
detergent/dextran (5.64 ± 1.34 kPa) had a similar modulus (Fig. 5A). The decellularization 
process caused a significant reduction in the dynamic modulus of the corneal stroma at 0.1 
Hz of agitated control (3.83 ± 1.99 kPa) and detergent (6.71 ± 2.49 kPa) corneas compared to 
the native tissue (15.20 ± 4.38 kPa), while detergent/dextran wash was not significantly 
different at 14.90 ± 3.66 kPa (Fig. 5B). In contrast, detergent/dextran displayed a 
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significantly higher modulus of 21.70 ± 2.45 kPa. There was a similar trend for 1 Hz dynamic 
modulus with agitated control (4.09 ± 2.55 kPa) and detergent (4.83 ± 1.37 kPa) being 
significantly lower than the native control (17.50 ± 5.13 kPa), while detergent/dextran wash 
displayed similar properties with a modulus of 19.00 ± 4.97 kPa (Fig. 5C). The dynamic 
modulus at 1 Hz for detergent/dextran was again significantly greater than the native cornea 
at 25.94 ± 2.88 kPa.  
 
Ultrastructure of the cornea and collagen fibril alignment 
Collagen fibril orientation and disruption to the corneal architecture following 
decellularization was examined using TEM (Fig. 6). The typical orthogonal fibril 
arrangement was evident in the native cornea, with collagen fibrils tightly packed within the 
tissue. The agitated control had similar structure, although the collagen bundles were more 
widely spaced due to corneal swelling. Decellularization with detergents alone caused a loss 
of collagen fibril alignment. The use of dextran revealed a more uniform arrangement of 
fibrils, with detergent/dextran most resembling the native cornea. Quantification of fibril 
alignment demonstrated a significant reduction in fibril alignment for detergent (0.14 ± 0.01) 
and detergent/dextran wash (0.15 ± 0.06) groups compared to the native control (0.24 ± 0.02) 
(Fig. 7A). Agitated control and detergent/dextran maintained similar fibril alignment to fresh 
stromal tissue with an anisotropy of 0.18 ± 0.04 and 0.22 ± 0.03 respectively. When fibril 
diameter was quantified (Fig. 7B), agitated control (28.78 ± 1.68 nm) and detergent/dextran  
(28.33 ± 1.23 nm) corneas had similar diameters compared to the native control (30.98 ± 2.46 
nm). However, detergent (25.58 ± 1.15 nm) and detergent/dextran wash (26.41 ± 2.36 nm) 
displayed a small but significant reduction in diameter. 
 
Scaffold biocompatibility 
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Cell viability assays demonstrated a small but significant increase in cell proliferation for all 
groups, except cells only and cells (DM), over the culture period of 14 days compared to day 
0 (Fig. 8).  There was an initial surge in cell proliferation for the first three days in the 
presence of corneal tissue. There was no significant difference in cell proliferation when 
comparing detergent and detergent/dextran to the agitated control at day 3, while 
detergent/dextran wash had significantly enhanced proliferation. By day 7 there was no 
significant difference between agitated control and detergent/dextran, however both detergent 
and detergent/dextran wash demonstrated significantly greater proliferation. At day 14 cell 
proliferation for both dextran treated corneas was similar to the agitated control, while that 
for detergent was significantly greater. Despite the significance observed the values for cell 
viability for each cornea treatment were in a similar range to each other, between ~105 - 115 
% cell viability over 14 days relative to day 0. Cells cultured in the presence of dextran 
showed a significant increase in cell proliferation at day 3 compared to cells alone, this 
continued to day 7 after which the cells behaved as in normal lgDMEM with no significant 
difference between the two by day 14. 
 
Discussion 
Decellularized scaffolds require that cellular and nuclear components of the tissue be 
removed while the composition and structure of the ECM are maintained (18, 20). This 
approach to biologic scaffold generation has been successful with a variety of tissue types 
and the resultant acellular ECM has been examined in both pre-clinical studies and human 
clinical applications (22, 40-42). One problem associated with corneal decellularization is 
control of tissue hydration (43-45). During an effective decellularization process the 
endothelium of the cornea is completely removed. The corneal endothelium is essential for 
maintaining human vision by regulating the hydration state of the stroma by way of Na+/K+-
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ATPase pump functioning (46-48). Once the cornea is denuded of the endothelium it 
undergoes extensive swelling (43-45). In this study, the use of dextran during 
decellularization was investigated to prevent swelling and maintain the discrete and complex 
features of the corneal ECM.  
 
Dextran is routinely used to maintain the hydration state of corneas in storage via colloid 
osmotic pressure (34). Prior to keratoplasty, a concentration of 5% dextran is routinely used 
to maintain graft thickness (35, 49, 50).  The addition of dextran during corneal 
decellularization has only been previously used in conjunction with ultrahigh hydrostatic 
pressure (HHP) (43, 44). The authors in these studies used dextran at a concentration of 
3.5%, although no rationale was provided for the use of this concentration. Sasaki et al. 
(2009) used dextran prior to decellularization to maintain the native corneas dimensions, 
however the effect of dextran was not described. Hashimoto et al. (2010) used dextran to 
prevent swelling during the washing step to avoid the swelling observed in during washing 
without dextran. Dextran was not used during the decellularization procedure itself. The 
examination of the effect of dextran was limited to swelling analysis that demonstrated a 
significant reduction in corneal thickness. There was no direct comparison of the addition of 
dextran to those without dextran in the decellularization process for other parameters 
analysed. The primary emphasis of these studies was on decellularization with HHP and not 
the addition of dextran. However, this decellularization method is limited by the need for 
expensive specialized equipment capable of applying pressures up to 1 GPa to the corneas 
(18). Our study used relatively inexpensive detergents and enzymes that are highly effective 
at removing cells and cellular debris. The addition of dextran during decellularization was 
successful in regulating scaffold water content. Corneas decellularized or washed in the 
presence of dextran displayed a marked decrease in swelling compared to those with 
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detergents and nucleases alone, with dimensions remaining similar to the native cornea, 
consistent with HHP studies. The extensive swelling observed for the agitated control can be 
attributed to the physiological pH, pH 7.40, of the PBS solution used. The isoelectric point of 
the cornea is considered to be close to pH 4 and the stroma undergoes hydration and swelling 
when moving away form this value (51, 52). The decellularization solutions used in this study 
were determined to be pH 4.00 and pH 4.07 for detergent and detergent/dextran, respectively. 
This suggests that dextran serves as an adjunct to the standard decellularization solution to 
prevent significant swelling. 
 
The concentrations of detergents in our study, 0.5% SDS and 1% Triton-X 100, have 
previously been used to effectively decellularize the cornea (28, 53-55). The use of detergents 
and nucleases for decellularization was effective in removing cellular components from the 
cornea and these results are consistent with other reports (23, 53, 54, 56). The effectiveness 
of this method is generally considered to be due to adequate disruption of the ECM enabling 
effective infiltration of decellularization factors into the scaffold (57). However, the addition 
of dextran restricts corneal swelling, minimizing ECM disruption. Despite this the 
decellularizing agents were able to infiltrate the scaffold effectively and remove cellular 
components.   
 
Biologic ECM scaffolds are an attractive choice for tissue engineering and regenerative 
applications since the structure and composition of ECM is similar between species (57, 58). 
Maintenance of these features will enhance the functionality of the scaffold although any 
protocol aimed at complete cellular removal will result in some ECM disruption (57, 59, 60). 
Furthermore, the ECM contains intrinsic biological signals, including growth factors and 
cytokines, that play an important role in the maintenance of cell migration, proliferation and 
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phenotype (19, 31, 61), and can affect the host remodelling response following in vivo 
implantation (58, 59, 61, 62). The GAG content after decellularization provides a useful 
indication as to the extent that biochemical cues and ECM components have been lost from 
the cornea. The concentration of GAGs was reduced in corneas decellularized using 
detergents even with the addition of dextran. Optimization of the concentration of detergents 
may improve the retention of GAGs in the ECM.    
 
In addition to biochemical cues, the ultrastructural and topographical characteristics of the 
tissue play an important role in modulating cell behaviour (62). In the case of the cornea, 
maintenance of collagen fibril alignment is essential for transparency of the replacement 
tissue. The predominant corneal collagen is collagen type I (27, 63). The uniform diameter 
and high level of lateral order of these fibrils gives the cornea its transparency (26). A simple 
method to evaluate the maintenance of this architecture, that is often employed, is to soak 
corneas in glycerol after decellularization (20, 56, 64) and evaluate changes macroscopically 
and by measuring light transmittance. Transparency was enhanced in all corneas after 
soaking in glycerol, however the dextran treated corneas had a similar level of light 
transmittance to the native cornea that was also treated in glycerol suggesting that the 
histoarchitecture of the stroma was maintained for these groups, similar results were obtained 
in the HHP studies using dextran. In addition, collagen content was maintained in all groups 
regardless of the decellularization method used. This is in agreement with previous 
decellularization studies carried out on annulus fibrosis tissue (65), tendon (66) and articular 
cartilage (67). Ultrastructural maintenance with TEM analysis demonstrated that scaffolds 
treated with detergent/dextran most closely resembled the native cornea. Our data showed 
that detergent alone had significantly enhanced light transmittance after glycerol treatment 
well above the level of the native tissue and greater than dextran treated corneas, however 
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TEM analysis confirmed significant disruption to the collagen architecture. It has been 
demonstrated that glycerol can reduce light scattering and improve the optical transmittance 
of scaffolds (68), however in this case glycerol could have disguised the damage caused to 
the cornea by the detergent only decellularization process. Fibril diameter plays an important 
role in corneal transparency. The corneal stroma consists of uniformly aligned collagen fibrils 
of 25 - 35 nm in diameter (69, 70). In this study, fibril diameter for treated samples ranged 
from 25.58 - 28.78 nm consistent with normal stromal diameters, despite the decrease 
observed for detergent and detergent/dextran wash groups. Collagen fibrils in the normal 
cornea are weak at scattering light as their diameter is smaller than the wavelength of light 
resulting in a transparent tissue (71). Collagen fibril diameter is increased in corneal wound 
and scar tissue resulting in increased light scattering (72, 73). Huang and Meek (1999) 
suggested that fibril diameter doesn’t change much over a range of hydrations, this is 
consistent with the data presented in this study that there was little change in fibril diameter 
and thusly fibril diameter has little impact on light transmittance in this study. 
 
The corneal mechanical properties can be ascribed to the gross arrangement of collagen 
fibrils within multiple lamellae that lie approximately parallel to the tissue surface (26). An 
engineered corneal replacement has to withstand suturing during surgery (74) in addition to 
membrane stresses caused by intraocular pressure and external forces such as eyelid pressure 
(30). Many strategies to engineer replacement tissue involve the use of soft hydrogels that 
have mechanical properties inferior to the native tissue (75).  The elastic modulus of the bulk 
cornea has previously been estimated by several different methods resulting in a wide range 
of values, 5 kPa to 20 MPa (30, 76-79). The modulus obtained depends on the testing 
method, testing conditions and orientation of the cornea with respect to applied stress (79). 
Hatami-Marbini et al.  performed out-of-plane compressive testing on corneal tissue and 
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found the compressive modulus could range between 0.6 and 13.8 kPa, and that the modulus 
increases with increasing strain (30, 78), consistent with our findings. Corneas treated with 
detergents alone had inferior mechanical properties compared to native corneas. This result 
correlates with a previous study that showed decellularization using SDS could reduce the 
ultimate tensile strength of the cornea from 4.5 MPa to 2.5 MPa (28). The addition of dextran 
enabled the decellularized scaffolds to retain the corneas mechanical characteristics. 
However, corneas treated with detergent/dextran resulted in an increased dynamic modulus 
ranging from 21 - 25 kPa compared to 15 -17 kPa for the native corneas.. Despite this 
increase the moduli determined are well within the limits of the normal cornea that have been 
determined previously in the literature. If a cornea is too weak it will be unusable as it will 
not be able to withstand the physiological loads experienced by the cornea. A cornea that is 
too stiff, however, can be detrimental to the functionality of a corneal replacement. Rigid 
artificial implants and keratoprostheses have experienced complications post-implantation 
including glaucoma, extrusion and rejection (80).  
 
The capacity of the scaffold to support host cells is essential when considering tissue-
engineering applications (18, 25, 54). Viability assays revealed that cells remained viable in 
the presence of decellularized corneas and may even enhance cell proliferation compared to 
cells alone. It has been demonstrated that extract from the corneal stroma contains active 
factors that can enhance keratocyte proliferation (81), which supports our findings. These 
results suggest that detergents added during the decellularization process that would have a 
detrimental effect on the cell viability are effectively removed by the washing process.   
 
Conclusion 
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It has been demonstrated that the addition of dextran can be used to control swelling and 
reduce structural ECM damage during corneal decellularization. These findings should 
enable researchers who are developing decellularization protocols to significantly refine their 
technique and produce decellularized scaffolds that closely resemble the structure and 
composition of the native human cornea.  
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Figure 1: (A) Macroscopic swelling analysis of decellularized corneas. (B) Mean thickness 
and (C) percentage swelling following decellularization (n = 12 ± standard deviation, * 
represents significant difference compared to native cornea, ‡ represents significant 
difference compared to detergent, p < 0.05). 
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Figure 2: (A) Macroscopic evaluation of tissue transparency following decellularization, 
with and without glycerol treatment. Percentage of light transmitted through corneas (B) 
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before glycerol treatment, (C) after soaking in 100 % glycerol for 18 h at 350 to 700 nm (n = 
8).  
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Figure 3: (A) Haematoxylin and Eosin stained corneal sections (top panel) scale bar = 100 
µm and 1 µm (insert); DAPI stained corneal sections (bottom panel) scale bar 200 µm and 2 
mm (insert). (B) Quantification of DNA from fresh and decellularized corneal tissue (n = 3, ± 
standard deviation, * represents significant difference compared to native cornea, p < 0.05). 
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Figure 4:  (A) Alcian blue and picrosirius red stained corneal sections, for sGAG and 
collagen respectively, scale bar = 100 µm and 1 mm (insert). (B) Quantification of sGAG and 
(C) collagen from fresh and decellularized corneal tissue (n = 3, ± standard deviation, * 
represents significant difference compared to native corneas, p < 0.05). 
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Figure 5: (A) Compressive modulus, (B) dynamic modulus at 0.1 Hz and (C) 1 Hz of control 
and decellularized corneas (n = 10, ± standard deviation, * represents significant difference 
compared to native cornea, ‡ represent significant difference compared to detergent, † 
represents significant difference compared to detergent/dextran, p < 0.05). 
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Figure 6: Transmission electron microscopy images of control and decellularized corneas; 
images depict collagen lamellae banding patterns, scale bar = 2 μm, collagen fibril bundles, 
scale bar = 1 μm, detail of fibrils, scale bar = 0.5 μm.  
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Figure 7: (A) Quantification of collagen fibril alignment and (B) collagen fibril diameter. (n 
= 3/4, ± standard deviation, * represents significant difference compared to native cornea, p < 
0.05).  
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Figure 8: Percentage of viable cells relative to day 0 as measured by cell proliferation at day 
0, 3, 7 and 14.  (n = 6, ± standard deviation).   
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